Comparison of Standard vs Higher Starting Dose of Insulin Glargine in Chinese Patients With Type 2 Diabetes (Glargine Starting Dose)

NCT02836704 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

892

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: INSULIN GLARGINE
DRUG: metformin
DRUG: acarbose

Sponsor

Sanofi